Version 1
: Received: 11 July 2023 / Approved: 12 July 2023 / Online: 12 July 2023 (12:28:48 CEST)
Version 2
: Received: 25 August 2023 / Approved: 28 August 2023 / Online: 29 August 2023 (09:18:30 CEST)
How to cite:
Halma, M. Disarming the Sword of Damocles: Biomarkers and Susceptibilities to Spike Protein Diseases. Preprints2023, 2023070840. https://doi.org/10.20944/preprints202307.0840.v2
Halma, M. Disarming the Sword of Damocles: Biomarkers and Susceptibilities to Spike Protein Diseases. Preprints 2023, 2023070840. https://doi.org/10.20944/preprints202307.0840.v2
Halma, M. Disarming the Sword of Damocles: Biomarkers and Susceptibilities to Spike Protein Diseases. Preprints2023, 2023070840. https://doi.org/10.20944/preprints202307.0840.v2
APA Style
Halma, M. (2023). Disarming the Sword of Damocles: Biomarkers and Susceptibilities to Spike Protein Diseases. Preprints. https://doi.org/10.20944/preprints202307.0840.v2
Chicago/Turabian Style
Halma, M. 2023 "Disarming the Sword of Damocles: Biomarkers and Susceptibilities to Spike Protein Diseases" Preprints. https://doi.org/10.20944/preprints202307.0840.v2
Abstract
Delineating the epidemic of vaccine injury from the coterminous condition long covid is a challenging prospect, but one with many implications not just for treatment, but also has important legal considerations for settlements of vaccine injury. The shared etiological factor of the spike protein in both vaccine injury and long covid make differentiation difficult, and while treatment is largely similar between vaccine injury and long covid, there are important distinctions. Furthermore, diagnostics are important for monitoring treatment progress and assessing the extent of subclinical vaccine injury in population having received a covid-19 vaccine. The development of rigorous diagnostics is an important step towards the recognition of both long covid and vaccine injury, as those suffering these conditions have faced immense challenges in having their conditions recognized, treated, and compensated by insurance companies or national health services.
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Commenter: Matthew Halma
Commenter's Conflict of Interests: Author